Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,520 | 2,030 | 3,410 | -2,650 | -3,800 |
| Depreciation Amortization | 650 | 430 | 210 | 690 | 540 |
| Other Working Capital | -930 | -1,010 | -330 | 260 | 720 |
| Other Operating Activity | -7,170 | -4,590 | -4,880 | 0 | 20 |
| Operating Cash Flow | $-3,930 | $-3,140 | $-1,590 | $-1,700 | $-2,520 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -350 | -270 | -140 | -5,400 | -4,650 |
| Other Investing Activity | -8,630 | 3,160 | -650 | -1,770 | -100 |
| Investing Cash Flow | $-8,980 | $2,890 | $-790 | $-7,170 | $-4,750 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 26,340 | 18,430 | 9,580 | 11,910 | 2,050 |
| Financing Cash Flow | $26,340 | $18,430 | $9,580 | $11,910 | $2,050 |
| Beginning Cash Position | 4,040 | 4,070 | 4,150 | 1,020 | 21,380 |
| End Cash Position | 17,470 | 22,250 | 11,350 | 4,060 | 16,150 |
| Net Cash Flow | $13,420 | $18,180 | $7,200 | $3,030 | $-5,220 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,930 | -3,140 | -1,590 | -1,700 | -2,520 |
| Free Cash Flow | -3,930 | -3,140 | -1,590 | -1,700 | -2,520 |